UV1
1 clinical trial
2 products
1 abstract
4 indications
1 target
Indication
OncologyIndication
Non-Small Cell Lung Cancer Stage IVIndication
NSCLCIndication
Stage IIITarget
hTertAbstract
Ipilimumab and nivolumab plus UV1, an anticancer vaccination against telomerase, in advanced melanoma.Org: AZ Sint-Augustinus,
Clinical trial
A Randomized Phase II, Open-label, Multicenter Study Investigating Efficacy and Safety of Pembrolizumab +/- UV1 Vaccination as First Line Treatment in Patients With Inoperable Advanced or Metastatic Non-small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2025-07-01
Product
UV1 + pembrolizumabProduct
Ipilimumab + Nivolumab + UV1